Switching Between Weight Loss Treatments: What You Need to Know
Can You Change From Wegovy to Mounjaro Based on Your Weight Loss Results?
The decision to change from Wegovy to Mounjaro depends on several clinical factors that your prescriber will evaluate. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual mechanism may provide different results for some patients, though both are prescription-only medicines that require medical supervision. Your prescriber will assess your current weight loss progress, any side effects experienced, and your individual response to determine whether switching treatments is clinically appropriate.
Patients considering whether they can change from Wegovy to Mounjaro should understand that both medications work alongside a reduced-calorie diet and increased physical activity. The transition between treatments requires careful medical oversight, including potential wash-out periods and adjusted dosing schedules. Your prescriber may recommend switching if your current results have plateaued, if you're experiencing persistent side effects, or if your clinical circumstances have changed since starting treatment.
Wegovy vs Mounjaro Pricing and Value Comparison at EverydayMeds
When evaluating whether you can change from Wegovy to Mounjaro, cost considerations often influence patient decisions. Wegovy pens at EverydayMeds start with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance dose of 2.4mg at £209.99. New customers can apply discount code FIRST40 at checkout to reach these final prices, whilst returning customers use code DOSE25. Our bundles provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99.
Mounjaro pricing follows a different structure due to its unique dual-hormone mechanism and different dose escalation schedule. Both medications require the same rigorous clinical assessment and prescriber review process at EverydayMeds. The choice between treatments should prioritise clinical suitability over cost alone, as your prescriber can determine which medication offers the best potential outcomes for your individual circumstances and weight management goals.
Clinical Evidence: Can Changing From Wegovy to Mounjaro Improve Weight Loss Results?
Clinical trial evidence provides insight into why patients might consider whether they can change from Wegovy to Mounjaro. The STEP 1 trial demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). STEP 3 showed even higher results of ~16% when combined with intensive behavioural therapy, whilst STEP 5 demonstrated sustained weight loss of ~15.2% at two years.
However, individual responses vary significantly, and some patients may not achieve optimal results with their initial treatment choice. Mounjaro's dual GIP and GLP-1 mechanism offers a different approach that may benefit patients who haven't responded adequately to single-hormone treatments. Your prescriber can evaluate your specific results and determine whether the clinical evidence supports switching between these prescription-only medicines based on your individual response pattern.
How Wegovy Works: Understanding the Mechanism Before Changing Treatments
Before deciding whether you can change from Wegovy to Mounjaro, it's essential to understand how Wegovy functions in your body. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone called glucagon-like peptide-1. This hormone is released from your intestines after eating and signals to your brain that you're full, promoting satiety and reducing appetite. The medication works on specific receptors in your brain's appetite control centres, potentially reducing food cravings and helping you feel satisfied with smaller meal portions. Wegovy also slows gastric emptying, which means food stays in your stomach longer, contributing to prolonged feelings of fullness throughout the day.
The EverydayMeds Ordering Process for Wegovy and Treatment Switches
Patients wondering if they can change from Wegovy to Mounjaro can access both treatments through our streamlined process at EverydayMeds. The journey begins with our comprehensive 3-minute online clinical assessment, which gathers essential information about your medical history, current medications, and weight management goals. Our qualified prescribers then review your assessment, typically within 3 working days (or 24 hours with our express service), to determine clinical suitability for your chosen treatment. Once approved, your prescription is fulfilled by our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using temperature-controlled packaging. This cold-chain delivery system ensures your medication maintains its effectiveness from our pharmacy to your door, whether you're continuing with Wegovy or switching to an alternative treatment.
Storage and Practical Considerations When Switching Treatments
Understanding storage requirements is crucial when considering whether you can change from Wegovy to Mounjaro, as both medications have specific temperature requirements. Wegovy must be stored in the refrigerator at 2-8°C before first use, though it offers a significant practical advantage with 6 weeks of room temperature stability once removed from the fridge (compared to Mounjaro's 21-day limit). The FlexTouch pen system makes administration straightforward, with dose escalation following a specific schedule from 0.25mg through to the 2.4mg maintenance dose. Each dose increase occurs every four weeks, and this escalation cannot be skipped as it allows your body to adjust gradually and minimises potential side effects. If switching treatments, your prescriber will provide specific guidance on timing and any necessary wash-out periods between medications.
UK-Specific Weight Loss Results: Why Patients Consider Changing From Wegovy to Mounjaro
UK patients often evaluate whether they can change from Wegovy to Mounjaro based on real-world weight loss results and lifestyle factors specific to British healthcare. The NHS recognises both treatments under specific criteria, with NICE TA875 recommending Wegovy alongside specialist weight management support. However, individual responses vary, and some patients find that their initial treatment choice doesn't align with their expectations or produces suboptimal results after the initial dose escalation period.
Climate and lifestyle factors in the UK also influence treatment decisions, particularly regarding storage and travel convenience. Wegovy's superior room temperature stability (6 weeks vs 21 days) makes it more practical for British patients who frequently travel or have unreliable refrigeration access. Additionally, the different side effect profiles between single-hormone and dual-hormone treatments mean that switching may be appropriate for patients who experience persistent gastrointestinal effects or other tolerability issues that impact their quality of life.
Making the Switch: Your Next Steps for Changing Treatments
If you're considering whether you can change from Wegovy to Mounjaro, EverydayMeds provides expert clinical support throughout your decision-making process. Our qualified prescribers can review your current treatment response, assess your weight loss progress, and evaluate whether switching treatments aligns with your clinical needs and goals. New customers can use discount code FIRST40 at checkout, whilst existing patients apply DOSE25 to access our competitive pricing on both treatment options. Remember that both Wegovy and Mounjaro are prescription-only medicines that require ongoing medical supervision, and any treatment changes should be made under professional guidance. Start your clinical assessment today at EverydayMeds, where our GPhC-registered pharmacy (#9012878) ensures you receive genuine medications with the clinical support you deserve for successful long-term weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
